Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

532 ARTÍCULOS , VIENDO DEL 106 AL 120

Editorial: Alzheimer's Disease Drug Development Pipeline 2020

Sabbagh MN.

J Prev Alzheimers Dis. 2020;7(2):66-67. doi: 10.14283/jpad.2020.12.

Refractory epilepsy in PSEN 1 mutation (I83T)

Fray S, Rassas A, Messaoud T, Belal S.

Neurocase. 2020 Jun;26(3):167-170. doi: 10.1080/13554794.2020.1747632. Epub 2020 Apr 3.

γ-Secretase inhibitors and modulators: Mechanistic insights into the function and regulation of γ-Secretase

Nie P, Vartak A, Li YM.

Semin Cell Dev Biol. 2020 Sep;105:43-53. doi: 10.1016/j.semcdb.2020.03.002. Epub 2020 Apr 2.

Oligomerization and Conformational Change Turn Monomeric β-Amyloid and Tau Proteins Toxic: Their Role in Alzheimer's Pathogenesis

Penke B, Szűcs M, Bogár F.

Molecules. 2020 Apr 3;25(7):1659. doi: 10.3390/molecules25071659.

Antagonism of cysteinyl leukotrienes and their receptors as a neuroinflammatory target in Alzheimer's disease

Singh RK.

Neurol Sci. 2020 Aug;41(8):2081-2093. doi: 10.1007/s10072-020-04369-7. Epub 2020 Apr 13.

Microbial acetylcholinesterase inhibitors for Alzheimer's therapy: recent trends on extraction, detection, irradiation-assisted production improvement and nano-structured drug delivery

Zaki AG, El-Sayed ER, Abd Elkodous M, El-Sayyad GS.

Appl Microbiol Biotechnol. 2020 Jun;104(11):4717-4735. doi: 10.1007/s00253-020-10560-9. Epub 2020 Apr 13.

Tau Protein Aggregation in Alzheimer's Disease: Recent Advances in the Development of Novel Therapeutic Agents

Monteiro KLC, Alcântara MGDS, de Aquino TM, da Silva-Júnior EF.

Curr Pharm Des. 2020;26(15):1682-1692. doi: 10.2174/1381612826666200414164038.

Alzheimer Drug Trials: Combination of Safe and Efficacious Biologicals to Break the Amyloidosis-Neuroinflammation Vicious Cycle

Bartfai T, Lees GV.

ASN Neuro. 2020 Jan-Dec;12:1759091420918557. doi: 10.1177/1759091420918557.

A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease

Hampel H, Caraci F, Cuello AC, Caruso G, Nisticò R, Corbo M, Baldacci F, Toschi N, Garaci F, Chiesa PA, Verdooner SR, Akman-Anderson L, Hernández F, Ávila J, Emanuele E, Valenzuela PL, Lucía A, Watling M, Imbimbo BP, Vergallo A, Lista S.

Front Immunol. 2020 Mar 31;11:456. doi: 10.3389/fimmu.2020.00456. eCollection 2020.

Estrogen Signaling in Alzheimer's Disease: Molecular Insights and Therapeutic Targets for Alzheimer's Dementia

Uddin MS, Rahman MM, Jakaria M, Rahman MS, Hossain MS, Islam A, Ahmed M, Mathew B, Omar UM, Barreto GE, Ashraf GM.

Mol Neurobiol. 2020 Jun;57(6):2654-2670. doi: 10.1007/s12035-020-01911-8. Epub 2020 Apr 15.

Recent Studies on Design and Development of Drugs Against Alzheimer's Disease (AD) Based on Inhibition of BACE-1 and Other AD-causative Agents

Gupta SP, Patil VM.

Curr Top Med Chem. 2020;20(13):1195-1213. doi: 10.2174/1568026620666200416091623.

The multi-faceted impact of methamphetamine on Alzheimer's disease: From a triggering role to a possible therapeutic use

Shukla M, Vincent B.

Ageing Res Rev. 2020 Jul;60:101062. doi: 10.1016/j.arr.2020.101062. Epub 2020 Apr 15.

Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders

Hook V, Yoon M, Mosier C, Ito G, Podvin S, Head BP, Rissman R, O'Donoghue AJ, Hook G.

Biochim Biophys Acta Proteins Proteom. 2020 Aug;1868(8):140428. doi: 10.1016/j.bbapap.2020.140428. Epub 2020 Apr 17.

Emerging Promise of Immunotherapy for Alzheimer's Disease: A New Hope for the Development of Alzheimer's Vaccine

Kabir MT, Uddin MS, Mathew B, Das PK, Perveen A, Ashraf GM.

Curr Top Med Chem. 2020;20(13):1214-1234. doi: 10.2174/1568026620666200422105156.

Recent Updates in the Alzheimer's Disease Etiopathology and Possible Treatment Approaches: A Narrative Review of Current Clinical Trials

Zarini-Gakiye E, Amini J, Sanadgol N, Vaezi G, Parivar K.

Curr Mol Pharmacol. 2020;13(4):273-294. doi: 10.2174/1874467213666200422090135.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias